STEPHANIE KEENER: Open Payments
NPI 1023618428 · XENIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 11 payments from 6 companies in 2025. Trend: 2023 $502 · 2024 $537 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $95 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| ABBVIE INC. | 1 | $17 |
| Gilead Sciences, Inc. | 1 | $15 |
Products named: REXULTI, INVEGA SUSTENNA, Auvelity, CAPLYTA, ABILIFY ASIMTUFII, VRAYLAR.
Industry payments across OH — which companies pay providers there.
